Bio-Path Holdings, Inc. Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market
HOUSTON, Jan. 23, 2019 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc. (Nasdaq: BPTH) (Bio-Path), a biotechnology company leveraging its proprietary DNAbilize® […]